Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Felix C. Wiegandt"'
Autor:
Felix C. Wiegandt, Ulrich P. Froriep, Fabian Müller, Theodor Doll, Andreas Dietzel, Gerhard Pohlmann
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 657 (2021)
A major disadvantage of inhalation therapy with continuous drug delivery is the loss of medication during expiration. Developing a breath-triggered drug release system can highly decrease this loss. However, there is currently no breath-triggered dru
Externí odkaz:
https://doaj.org/article/ba014bccf4cd4d04aadb675a954222a9
Autor:
Felix C. Wiegandt, David Biegger, Jacob F. Fast, Grzegorz Matusiak, Jan Mazela, Tobias Ortmaier, Theodor Doll, Andreas Dietzel, Bettina Bohnhorst, Gerhard Pohlmann
Publikováno v:
Pharmaceutics, Vol 13, Iss 5, p 721 (2021)
In order to deliver an aerosolized drug in a breath-triggered manner, the initiation of the patient’s inspiration needs to be detected. The best-known systems monitoring breathing patterns are based on flow sensors. However, due to their large dead
Externí odkaz:
https://doaj.org/article/f50e90cf4fc3438e8ae598f75578cc81
Autor:
David Biegger, Andreas Dietzel, Bettina Bohnhorst, Tobias Ortmaier, Grzegorz Matusiak, Theodor Doll, Jan Mazela, Gerhard Pohlmann, Felix C Wiegandt, Jacob Friedemann Fast
Publikováno v:
Pharmaceutics
Volume 13
Issue 5
Pharmaceutics, Vol 13, Iss 721, p 721 (2021)
Volume 13
Issue 5
Pharmaceutics, Vol 13, Iss 721, p 721 (2021)
In order to deliver an aerosolized drug in a breath-triggered manner, the initiation of the patient’s inspiration needs to be detected. The best-known systems monitoring breathing patterns are based on flow sensors. However, due to their large dead
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1518eb95452422ad5a37aedbc6760b
https://publica.fraunhofer.de/handle/publica/268548
https://publica.fraunhofer.de/handle/publica/268548
Autor:
Ulrich P. Froriep, Fabian Muller, Gerhard Pohlmann, Andreas Dietzel, Felix C Wiegandt, Theodor Doll
Publikováno v:
Pharmaceutics, Vol 13, Iss 657, p 657 (2021)
Pharmaceutics
Volume 13
Issue 5
Pharmaceutics
Volume 13
Issue 5
A major disadvantage of inhalation therapy with continuous drug delivery is the loss of medication during expiration. Developing a breath-triggered drug release system can highly decrease this loss. However, there is currently no breath-triggered dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10072751f35dc70cb37833b422c29b91
https://publica.fraunhofer.de/handle/publica/268532
https://publica.fraunhofer.de/handle/publica/268532
Publikováno v:
Journal of Aerosol Medicine and Pulmonary Drug Delivery
Background: Developing new (triggered) or improving existing inhaler systems for (preterm) neonates and adults requires test benches for the determination of aerosol output and aerosol output rate. Furthermore, real-time measurement of aerosol output
Autor:
'Felix C Wiegandt
Publikováno v:
David Biegger